CN1024754C - 抗菌冻干制剂 - Google Patents

抗菌冻干制剂 Download PDF

Info

Publication number
CN1024754C
CN1024754C CN88100164A CN88100164A CN1024754C CN 1024754 C CN1024754 C CN 1024754C CN 88100164 A CN88100164 A CN 88100164A CN 88100164 A CN88100164 A CN 88100164A CN 1024754 C CN1024754 C CN 1024754C
Authority
CN
China
Prior art keywords
aspoxicillin
freeze
antibacterial
salt
injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN88100164A
Other languages
English (en)
Chinese (zh)
Other versions
CN1034131A (zh
Inventor
河野启一
三浦博
平川善行
植木俊行
森国诚一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of CN1034131A publication Critical patent/CN1034131A/zh
Application granted granted Critical
Publication of CN1024754C publication Critical patent/CN1024754C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN88100164A 1987-01-14 1988-01-13 抗菌冻干制剂 Expired - Fee Related CN1024754C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP62006868A JPS63174927A (ja) 1987-01-14 1987-01-14 抗菌性凍結乾燥製剤
JP6868/87 1987-01-14

Publications (2)

Publication Number Publication Date
CN1034131A CN1034131A (zh) 1989-07-26
CN1024754C true CN1024754C (zh) 1994-06-01

Family

ID=11650214

Family Applications (1)

Application Number Title Priority Date Filing Date
CN88100164A Expired - Fee Related CN1024754C (zh) 1987-01-14 1988-01-13 抗菌冻干制剂

Country Status (18)

Country Link
US (1) US4966899A (OSRAM)
EP (1) EP0278243B1 (OSRAM)
JP (1) JPS63174927A (OSRAM)
KR (1) KR930001830B1 (OSRAM)
CN (1) CN1024754C (OSRAM)
AT (1) ATE61222T1 (OSRAM)
AU (1) AU597463B2 (OSRAM)
CA (1) CA1308358C (OSRAM)
DE (1) DE3861866D1 (OSRAM)
DK (1) DK15088A (OSRAM)
ES (1) ES2031930T3 (OSRAM)
FI (1) FI89454C (OSRAM)
GR (1) GR3001565T3 (OSRAM)
HK (1) HK63592A (OSRAM)
HU (1) HU197985B (OSRAM)
IE (1) IE60049B1 (OSRAM)
IL (1) IL85031A (OSRAM)
SG (1) SG60292G (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68912270T2 (de) * 1988-11-01 1994-04-28 Sanol Arznei Schwarz Gmbh Lyophilisiertes MDM enthaltende Zusammensetzung und Verfahren zu deren Herstellung.
AU700545B2 (en) * 1994-05-02 1999-01-07 Shionogi & Co., Ltd. Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
US8252228B1 (en) * 2008-10-13 2012-08-28 Abbott Cardiovascular Systems Inc. Methods for sterilizing carriers for treatment of a kidney
CN102372727A (zh) * 2010-08-10 2012-03-14 海南美好西林生物制药有限公司 一种阿扑西林钠的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3733404A (en) * 1970-09-04 1973-05-15 Squibb & Sons Inc Antibacterial composition containing alpha-aminobenzyl penicillins
US4053609A (en) * 1975-09-12 1977-10-11 Tanabe Seiyaku Co., Ltd. Penicillins and processes for preparing the same
DE2623835C2 (de) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von Natriumampicillin
GB1539510A (en) * 1976-08-23 1979-01-31 Beecham Group Ltd Injectable compositions
JPS5640686A (en) * 1979-09-11 1981-04-16 Tanabe Seiyaku Co Ltd Purification of penicillin derivative
CA1242699A (en) * 1985-02-01 1988-10-04 Bristol-Myers Company Cefbuperazone and derivatives thereof

Also Published As

Publication number Publication date
SG60292G (en) 1992-09-04
IL85031A (en) 1992-07-15
EP0278243A1 (en) 1988-08-17
GR3001565T3 (en) 1992-11-23
DK15088A (da) 1988-07-15
FI89454C (fi) 1993-10-11
FI880027L (fi) 1988-07-15
KR880008812A (ko) 1988-09-13
IE880049L (en) 1988-07-14
DE3861866D1 (de) 1991-04-11
JPS63174927A (ja) 1988-07-19
FI880027A0 (fi) 1988-01-06
CN1034131A (zh) 1989-07-26
IE60049B1 (en) 1994-05-18
HUT46212A (en) 1988-10-28
US4966899A (en) 1990-10-30
ES2031930T3 (es) 1993-01-01
HK63592A (en) 1992-08-28
CA1308358C (en) 1992-10-06
JPH053847B2 (OSRAM) 1993-01-18
ATE61222T1 (de) 1991-03-15
HU197985B (en) 1989-07-28
EP0278243B1 (en) 1991-03-06
FI89454B (fi) 1993-06-30
KR930001830B1 (ko) 1993-03-15
DK15088D0 (da) 1988-01-13
AU597463B2 (en) 1990-05-31
AU1022688A (en) 1988-07-21

Similar Documents

Publication Publication Date Title
CN1055090C (zh) 结晶性头孢噻夫游离酸
CN100346779C (zh) 液体药物组合物
JP2000513029A (ja) ボリコナゾールを含有する薬剤製剤
CN1368891A (zh) 莫西沙星/氯化钠制剂
CN1011572B (zh) 制备含喹诺酮羧酸的碱性制剂的方法
JP2001505910A (ja) 改良医薬組成物
CN1198162A (zh) 碳代青霉烯类抗菌素、组合物及其制备方法
CN1177300A (zh) 恩氟沙星注射液或输液
CN1024754C (zh) 抗菌冻干制剂
CN1121875C (zh) 适于冷冻干燥的药物组合物
ES2553107T3 (es) Composición anti-inflamatoria basada en compuestos de estroncio
CN1022023C (zh) 含哌啶子基链烷醇衍生物的液体药物组合物的制备方法
JPS6119605B2 (OSRAM)
CN1053185A (zh) 可注射溶液及其制备方法
CN1694709A (zh) 具有改善的口服吸收性的抗菌药物组合物
JP2761005B2 (ja) セファロスポリン含有注射用組成物
CN1021225C (zh) 稳定的青霉素衍生物的水合物的制备方法
EP0918520A1 (en) Process for preparing potassium clavulanate
PT91383B (pt) Processo para a preparacao do acido (5r,6s)-2-carbamoiloximetil-6-{(1r)-hidroxi-etil}-2-penem-3-carboxilico sob a forma cristalina e de composicoes farmaceuticas que o contem
EP0381915B1 (en) Process for preparing alkali metal salts of 3,7-substituted 7-aminocephalosporanic acid derivatives.
JP2003300885A (ja) 抗菌性医薬組成物
JPH053848B2 (OSRAM)
JP2004269401A (ja) 凍結乾燥製剤
KR910001310B1 (ko) 3-치환기-7-치환된 아미노기 세팔로스포란산 유도체의 알칼리 금속염과 그의 제조법
HK1081451B (en) Medicinal composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee